Regencell Bioscience Holdings Limited (RGC) Capital expenditures 2020–2025
Regencell Bioscience Holdings Limited (RGC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$152,689FY2025 · since FY2020: $117,837 → $152,689
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $152,689 | +2740.2% |
| FY2024 | $5,376 | -80.4% |
| FY2023 | $27,392 | -96.5% |
| FY2022 | $780,876 | — |
| FY2020 | $117,837 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice